NEW YORK, July 16 - French genomics company Genset said today it has decided to shutter its San Diego R&D facility.
The space is home to Genset's preclinical metabolic-disorder research group and all its US administrative support, 46 employees in all. The research performed at the facility will be integrated into Genset's space in Evry, France.
It was not immediately clear if the San Diego staff was given the option of relocating to Evvry.
Genset hinted last month that it might close the facility, a decision that it said coincided with, but did not center on, the firm becoming an acquisition target by Swiss functional-genomics shop Serono.
In late June, Serono, based in Geneva, said it planned to buy Genset for €107.4 million, or $106.5 million. Genset's center in Evry will become Serono's worldwide genetics headquarters, and Genset's Paris-based support staff will be transferred to the Evry site.
About 20 percent of Genset's workforce of 250 will be laid off. A company representative said last month that the layoffs will be concentrated in administration and support rather than in R&D.